Zavzpret Spray
Product Images NDC 0069-3500

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Zavzpret (NDC 0069-3500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zavegepant 01)

FDA Label Image

Figure 1 (Zavegepant 02)

FDA Label Image

Figure 2 (Zavegepant 03)

FDA Label Image

Figure 3 (Zavegepant 04)

FDA Label Image

Figure 4 (Zavegepant 05)

FDA Label Image

Logo (Zavegepant 06)

Stfier is a product that is distributed by Pfizer Labs, a division of Pfizer Inc. based in New York. It is not possible to provide any further information based on the limited text provided.*

FDA Label Image

Logo (Zavegepant 07)

Stfier is distributed by Pfizer Labs, a division of Pfizer Inc. located in New York, NY 10001.*

FDA Label Image

Figure A (Zavegepant 08)

Not available.*

FDA Label Image

Figure B (Zavegepant 09)

FDA Label Image

Figure C (Zavegepant 10)

FDA Label Image

Figure D (Zavegepant 11)

FDA Label Image

Figure E (Zavegepant 12)

FDA Label Image

Figure F (Zavegepant 13)

FDA Label Image

Figure G (Zavegepant 14)

FDA Label Image

Figure H (Zavegepant 15)

FDA Label Image

Figure I (Zavegepant 16)

FDA Label Image

Figure J (Zavegepant 17)

FDA Label Image

Figure K (Zavegepant 18)

The text describes a breathing exercise to be performed by inhaling through the nose and exhaling through the mouth for a duration of 10-20 seconds. It is accompanied by a figure labeled K.*

FDA Label Image

Figure L (Zavegepant 19)

FDA Label Image

Logo (Zavegepant 20)

Stfier is a product distributed by Pfizer Labs, which is a division of Pfizer Inc. based in New York, NY 10001.*

FDA Label Image

Principal Display Panel – Nasal Spray Device Label Front (Zavzpret 07)

Zavegepant nasal spray is a medication meant for intranasal use only with a strength of 10mg. The product is identified by the NDC number 0069-3500-01. No other information is available due to the limited and unclear text obtained by .*

FDA Label Image

Principal Display Panel – Nasal Spray Device Label Back (Zavzpret 08)

FDA Label Image

Principal Display Panel – Nasal Spray Blister Foil Label (Zavzpret 09)

This is a medication description for Zavegepant nasal spray, with the NDC code 0069-3500-01. Each unit-dose device contains 10 mg of the medication, and should only be used intranasally. The recommended dosage can be found in the prescribing information, and the device should be kept in the sealed blister package until use. The medication should be stored at 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F), and should not be frozen. The spray should not be tested or primed before use, and the device should be kept out of reach of children. This medication is distributed by Pfizer Inc. from New York, NY.*

FDA Label Image

Principal Display Panel – Nasal Spray Carton (Zavzpret 10)

This appears to be a description of a nasal spray, containing 10mg of a medication. The name of the medication is not available as it was not provided in the text. The text "Zavzpret:z T ." and "buw oy Aesds jeseu" are not readable and may be errors.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.